Validation results of SmartChip Real-Time PCR System to be presented at CHI's conference

WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art genetic analysis systems, today announced that WaferGen scientists will present validation results of the company's SmartChip™ Real-Time PCR System at Cambridge Healthcare Institute's 17th International Molecular Medicine Tri-Conference.  The conference is being held from February 3-5, 2010 at the Moscone North Convention Center in San Francisco.

Details of the poster presentation are as follows:

Title:  "Performance of the SmartChip System from WaferGen"

Time:  Beginning at 9:40 a.m. PST on Wednesday, February 3 until 3:45 p.m. PST on Thursday, February 4.

Summary: An overview of the company's novel whole genome, high-throughput SmartChip Real-Time PCR System, and data to demonstrate the system's ability to quantify gene expression levels by real-time PCR for a large number of genes at one time utilizing a simple workflow.

WaferGen's SmartChip Real-Time PCR System consists of three components:  a SmartChip, comprising 5184 nanowells preprogrammed with gene-specific reaction content; a SmartChip Nanodispenser for applying sample and reaction mix to the SmartChips; and a SmartChip Cycler for performing and collecting data from the real-time PCR assays.  WaferGen's SmartChip Human Oncology Gene Panel was used to quantify changes in gene expression levels in breast and lung tumors. Data from the study support the conclusion that WaferGen's SmartChip system provides an easy solution to perform massively parallel gene expression studies using real-time PCR technology.  In addition, the availability of content-ready chips allows for an easy workflow for the researcher.  Finally, the system allows analysis of thousands of genes using low (0.5 mg) sample input.